Ad hoc announcements

Ad hoc announcement pursuant to Art. 53 LR

Would you like to join our distribution list or receive press releases electronically? Register here: https://www.hocn.ch/newsletter

Do you have any questions about the HOCHDORF Group? Please contact:

gl_office@hochdorf.com‍​​​​​​​
+41 41 914 66 15

2024

24
.
09
.
HOCHDORF Holding Ltd: Shareholder changes
18
.
09
.
Shareholders open the way for HOCHDORF’s operating business to continue
11
.
09
.
HOCHDORF Holding confirms its proposal to shareholders for the sale of HOCHDORF Swiss Nutrition to AS Equity Partners
27
.
08
.
HOCHDORF Group half-year results: operational turnaround on track; agreed sale of HOCHDORF Swiss Nutrition results in a net accounting loss
27
.
08
.
Sale of HOCHDORF Swiss Nutrition to AS Equity Partners agreed
15
.
05
.
HOCHDORF Annual General Meeting: Shareholders confirm the existing Board of Directors
03
.
05
.
Shareholder motions for the Annual General Meeting of HOCHDORF Holding Ltd.
22
.
04
.
HOCHDORF publishes agenda for the Annual General Meeting and provides information on financial legacy and prospects
21
.
03
.
Positive operating result for HOCHDORF – approach of investors launched
05
.
03
.
HOCHDORF: Update on 2023 business performance and strategic options for financial restructuring

2023

11
.
09
.
HOCHDORF on course operationally: pleasing first half year
24
.
08
.
HOCHDORF makes significant operational progress and gains time
23
.
03
.
HOCHDORF macht deutliche operative Fortschritte und verschafft sich Zeit

2022

15
.
11
.
HOCHDORF: Pleasing net sales revenue – material and energy costs negatively influence half-year result
08
.
08
.
HOCHDORF: Nettoerlös erfreulich – Material- und Energiekosten beeinflussen Halbjahresergebnis negativ
22
.
06
.
CFO change at the HOCHDORF Group
14
.
03
.
Pleasing balance sheet improvement and difficult milk year
21
.
01
.
Peter Pfeilschifter to leave HOCHDORF Swiss Nutrition Ltd - Ralph Siegl appointed CEO

2021

16
.
12
.
HOCHDORF sells site to the Hochdorf municipality
31
.
08
.
HOCHDORF takes next steps towards financial recovery and strategic focus
16
.
08
.
Interim Results 2021: Creating a solid foundation for a successful future
28
.
06
.
HOCHDORF reaches agreement with syndicate banks
09
.
06
.
Shareholders accept Board of Directors’ recommendations
12
.
04
.
HOCHDORF – strategic and operational foundations developed
10
.
03
.
HOCHDORF postpones Annual Results Press Conference and Annual General Meeting

2020

11
.
09
.
HOCHDORF on course operationally: pleasing first half year
24
.
08
.
HOCHDORF makes significant operational progress and gains time
23
.
03
.
HOCHDORF macht deutliche operative Fortschritte und verschafft sich Zeit

2019

19
.
12
.
HOCHDORF-Gruppe erhält Antrag zur Einberufung einer ausserordentlichen Generalversammlung
19
.
12
.
HOCHDORF Group receives motion to convene Extraordinary General Meeting
13
.
12
.
Closing of the sale of the Pharmalys stake to Pharmalys Invest Holding
08
.
12
.
HOCHDORF sells Pharmalys stake to Pharmalys Invest Holding
14
.
11
.
Jürgen Brandt appointed new CFO of the HOCHDORF Group
21
.
08
.
Amir Mechria resigns from the Board of Directors of Pharmalys Laboratories SA
20
.
08
.
HOCHDORF must realign itself
07
.
08
.
Sale of HOCHDORF South Africa Ltd
08
.
07
.
HOCHDORF realigns its business
13
.
05
.
Integration of subsidiaries bigger challenge than expected – strategy update announced
12
.
04
.
Shareholders focus on fresh impetus – HOCHDORF receives four new board members
19
.
03
.
Implementation of strategy continues – expected earnings not yet realised
13
.
03
.
Nominations for the Board of Directors
11
.
03
.
Dr Thomas Eisenring resigns as CEO

2018

10
.
12
.
Sales delays and inventory write-downs impact net income
21
.
11
.
Milk from Eastern Switzerland for HOCHDORF infant formula
30
.
08
.
HOCHDORF expecting a significant improvement in the second half of the year
18
.
07
.
Michel Burla to leave the HOCHDORF Group at the end of this year
19
.
06
.
HOCHDORF parts company with milk plant in Lithuania
24
.
05
.
HOCHDORF takes over traditional Swiss brand Bimbosan
07
.
05
.
Dividend increase thanks to good result
05
.
04
.
HOCHDORF: Successful forward integration
29
.
03
.
Werner Schweizer is succeeded by Dr Peter Pfeilschifter
31
.
01
.
Dr Karl Gschwend to retire

2017

21
.
11
.
HOCHDORF successfully places public hybrid bond (SIX/
14
.
11
.
HOCHDORF presents a new quality standard for oils
01
.
11
.
HOCHDORF strengthens its position in Cereals & Ingredients
17
.
08
.
Higher earnings thanks to Pharmalys’ participation
04
.
07
.
Uckermärker Milch to reposition itself on the market
08
.
05
.
Dr Daniel Suter takes on the role of Chairman
28
.
03
.
Closing of the Offering
13
.
03
.
Launch of the mandatory convertible securities
13
.
03
.
HOCHDORF posts record earnings in 2016
26
.
01
.
Sales maintained at last year’s level despite low milk price
Close Cookie Popup
Cookie settings
By clicking "Accept all cookies", you agree to storing cookies on your device to enhance site navigation, analyze site usage and assist in our marketing efforts as outlined in our privacy policy.
Accept all cookiesCookie settings
Close Cookie Preference Manager
Cookie settings
By clicking 'Accept all cookies', you agree to storing cookies on your device to enhance site navigation, analyze site usage and assist in our marketing efforts as outlined in our privacy policy.
Strictly necessary (always active)
Cookies required to enable basic website functionality.
Accept all cookiesSave settings